Ausgabe 6/2002
Inhalt (13 Artikel)
HMG CoA reductase inhibitors and PPAR-α activators: Are their effects on high-density lipoprotein cholesterol and their pleiotropic effects clinically relevant in prevention trials?
Jean-Charles Fruchart, Patrick Duriez
Update on the role of triglycerides as a risk factor for coronary heart disease
Michael Miller, Barbara Cosgrove, Stephen Havas
Therapeutic lifestyle change and adult treatment panel III: Evidence then and now
Neil J. Stone, Linda Van Horn
Dietary patterns and risk of hypertension, type 2 diabetes mellitus, and coronary heart disease
Matthias B. Schulze, Frank B. Hu
Cardiorespiratory fitness and physical activity as risk predictors of future atherosclerotic cardiovascular diseases
Jari A. Laukkanen, Sudhir Kurl, Jukka T. Salonen